These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 16482202)

  • 1. Mosaic vectors comprised of modified AAV1 capsid proteins for efficient vector purification and targeting to vascular endothelial cells.
    Stachler MD; Bartlett JS
    Gene Ther; 2006 Jun; 13(11):926-31. PubMed ID: 16482202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
    Nicklin SA; Buening H; Dishart KL; de Alwis M; Girod A; Hacker U; Thrasher AJ; Ali RR; Hallek M; Baker AH
    Mol Ther; 2001 Sep; 4(3):174-81. PubMed ID: 11545607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes.
    Arnold GS; Sasser AK; Stachler MD; Bartlett JS
    Mol Ther; 2006 Jul; 14(1):97-106. PubMed ID: 16624620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery to the vasculature mediated by low-titre adeno-associated virus serotypes 1 and 5.
    Sen S; Conroy S; Hynes SO; McMahon J; O'Doherty A; Bartlett JS; Akhtar Y; Adegbola T; Connolly CE; Sultan S; Barry F; Katusic ZS; O'Brien T
    J Gene Med; 2008 Feb; 10(2):143-51. PubMed ID: 18067196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
    Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
    Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor targeting of adeno-associated virus vectors.
    Büning H; Ried MU; Perabo L; Gerner FM; Huttner NA; Enssle J; Hallek M
    Gene Ther; 2003 Jul; 10(14):1142-51. PubMed ID: 12833123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect.
    Su H; Huang Y; Takagawa J; Barcena A; Arakawa-Hoyt J; Ye J; Grossman W; Kan YW
    Gene Ther; 2006 Nov; 13(21):1495-502. PubMed ID: 16775632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain.
    Broekman ML; Comer LA; Hyman BT; Sena-Esteves M
    Neuroscience; 2006; 138(2):501-10. PubMed ID: 16414198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors.
    Müller OJ; Kaul F; Weitzman MD; Pasqualini R; Arap W; Kleinschmidt JA; Trepel M
    Nat Biotechnol; 2003 Sep; 21(9):1040-6. PubMed ID: 12897791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiency.
    Hacker UT; Wingenfeld L; Kofler DM; Schuhmann NK; Lutz S; Herold T; King SB; Gerner FM; Perabo L; Rabinowitz J; McCarty DM; Samulski RJ; Hallek M; Büning H
    J Gene Med; 2005 Nov; 7(11):1429-38. PubMed ID: 15945124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo.
    Palomeque J; Chemaly ER; Colosi P; Wellman JA; Zhou S; Del Monte F; Hajjar RJ
    Gene Ther; 2007 Jul; 14(13):989-97. PubMed ID: 17251988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential internalization and nuclear uncoating of self-complementary adeno-associated virus pseudotype vectors as determinants of cardiac cell transduction.
    Sipo I; Fechner H; Pinkert S; Suckau L; Wang X; Weger S; Poller W
    Gene Ther; 2007 Sep; 14(18):1319-29. PubMed ID: 17611587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsid modifications overcome low heterogeneous expression of heparan sulfate proteoglycan that limits AAV2-mediated gene transfer and therapeutic efficacy in human ovarian carcinoma.
    Shi W; Hemminki A; Bartlett JS
    Gynecol Oncol; 2006 Dec; 103(3):1054-62. PubMed ID: 16870238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AAV display--homing in on the target.
    Lieber A
    Nat Biotechnol; 2003 Sep; 21(9):1011-3. PubMed ID: 12949562
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
    Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
    Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical gene therapy using recombinant adeno-associated virus vectors.
    Mueller C; Flotte TR
    Gene Ther; 2008 Jun; 15(11):858-63. PubMed ID: 18418415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.
    Halbert CL; Allen JM; Miller AD
    Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CMV-actin-globin hybrid promoter improves adeno-associated viral vector gene expression in the arterial wall in vivo.
    Nitta Y; Kawamoto S; Halbert C; Iwata A; Miller AD; Miyazaki J; Allen MD
    J Gene Med; 2005 Oct; 7(10):1348-55. PubMed ID: 15945122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting.
    Campos SK; Barry MA
    Virology; 2006 Jun; 349(2):453-62. PubMed ID: 16504233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.